[
  {
    "ts": "2025-01-17T12:22:34+00:00",
    "headline": "Charles River and Akron link to integrate cytokines into cell therapy",
    "summary": "The integration enables closed system processing, a significant step in automating platforms and protocols for cell therapies.",
    "url": "https://www.pharmaceutical-technology.com/news/charles-river-akron-cell-therapy/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "0c87b697-3a79-341c-9762-094eaea589ab",
      "content": {
        "id": "0c87b697-3a79-341c-9762-094eaea589ab",
        "contentType": "STORY",
        "title": "Charles River and Akron link to integrate cytokines into cell therapy",
        "description": "",
        "summary": "The integration enables closed system processing, a significant step in automating platforms and protocols for cell therapies.",
        "pubDate": "2025-01-17T12:22:34Z",
        "displayTime": "2025-01-17T12:22:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/7ae2b12fb0311afe4183b112b0c79241",
          "originalWidth": 1440,
          "originalHeight": 961,
          "caption": "Charles Riverâ€™s Cell Therapy Flex Platform is an off-the-shelf solution for cell therapy process development. Credit: Stock-Asso/Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NUpX5SCTsVv.PB2eIiAVEQ--~B/aD05NjE7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/7ae2b12fb0311afe4183b112b0c79241.cf.webp",
              "width": 1440,
              "height": 961,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BRslq0abIELjDLyqeO93og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/7ae2b12fb0311afe4183b112b0c79241.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/charles-river-akron-cell-therapy/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-akron-integrate-cytokines-122234617.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-01-17T11:15:00+00:00",
    "headline": "Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?",
    "summary": "Charles River and Akron Bio collaborate to boost operations by integrating CGMP materials into the Cell Therapy Platform.",
    "url": "https://finance.yahoo.com/news/crl-stock-gain-integration-akron-111500838.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bb9d862b-edde-364d-a295-a22317471043",
      "content": {
        "id": "bb9d862b-edde-364d-a295-a22317471043",
        "contentType": "STORY",
        "title": "Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?",
        "description": "",
        "summary": "Charles River and Akron Bio collaborate to boost operations by integrating CGMP materials into the Cell Therapy Platform.",
        "pubDate": "2025-01-17T11:15:00Z",
        "displayTime": "2025-01-17T11:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crl-stock-gain-integration-akron-111500838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crl-stock-gain-integration-akron-111500838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "HAE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]